Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Validity of The Timed Up and Go as A Measure of Functional Mobility in Persons with Multiple Sclerosis.
FLT PET/CT in a Case of Demyelinating Disease.
IFN-β differentially regulates the function of T cell subsets in MS and EAE.
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.
Neurogenic vision loss: Causes and outcome. An experience from a tertiary center in Northern India.
Bochum ultrasound score versus clinical and electrophysiological parameters in distinguishing acute-onset chronic from acute inflammatory demyelinating polyneuropathy.
The Scandinavian paradox revisited: Editorial comment on Berg-Hansen et al. 'High prevalence and no latitude gradient of multiple sclerosis in Norway'.
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.
Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.
Aerobic intensity and pacing pattern during the six-minute walk-test in patients with multiple sclerosis.
Olfactory dysfunction in patients with neuromyelitis optica.
Design of Peptide Immunotherapies for MHC Class-II-Associated Autoimmune Disorders.
Modulation of Immune response by Ultra-violet light in HLA class-II transgenic mice.
[STUDY ON RELATIONSHIP BETWEEN DIFFUSION TENSOR IMAGING AND VISUAL EVOKED POTENTIAL IN VISUAL PATHWAY OF NEUROMYELITIS OPTICA].
1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities.
Multiple Roles for Nogo Receptor 1 in Visual System Plasticity.
Patient-reported outcomes in multiple sclerosis: Relationships among existing scales and the development of a brief measure.
[PET-patterns of cognitive impairment in patients with multiple sclerosis.]
[Physiotherapy and neurogenic lower urinary tract dysfunction in multiple sclerosis patients: A randomized controlled trial].
Development of a Human Dihydroorotate Dehydrogenase (hDHODH) Pharma-Similarity Index Approach with Scaffold-Hopping Strategy for the Design of Novel Potential Inhibitors.
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.
The Inflammasome Pyrin Contributes to Pertussis Toxin-Induced IL-1β Synthesis, Neutrophil Intravascular Crawling and Autoimmune Encephalomyelitis.
Autoimmune Demyelinating Polyneuropathy as a Manifestation of Chronic Graft-versus-Host Disease after Adult Cord Blood Transplantation in a Patient with Chronic Lymphocytic Leukemia.
Cross-Recognition of a Myelin Peptide by CD8+ T Cells in the CNS Is Not Sufficient to Promote Neuronal Damage.
Defective structural RNA processing in relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
517
518
519
520
521
522
523
524
525
…
next ›
last »